(Q93483936)
Statements
OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector (English)
R Dolin
KL O'Brien
P Abbink
A La Porte
MS Seaman
E Choi
R Tucker
M Weitjens
MG Pau
J Goudsmit